Stacie is a pharmaceutical R&D and biotech leader with 17+ years’ experience in strategically framing problems and infusing pace in the implementation of creative healthcare solutions. She is the Vice Chair of the Alliance for Artificial Intelligence in Healthcare (AAIH), a coalition working to establish standards for the development and implementation of AI in healthcare and life sciences. As the Chief Strategy Officer at BioSymetrics she guided the company on its drug discovery and partnering strategies, with a focus on translating human-relevant disease biology. Prior to that, Stacie worked as an independent consultant in the AI-powered drug discovery space and led collaborations and partnerships as Vice President and Head of AI Molecular Screening Partnerships at Atomwise. Previously she established and co-led the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, a public-private partnership developing machine learning tools to accelerate drug discovery. She worked at GSK for more than 13 years, starting as a process chemist and moving into R&D strategy and operations roles where she led several change initiatives and teams. Stacie holds a B.S. in Chemistry from University of California Berkeley and a Ph.D. in chemistry from University of California Irvine.